Showing results (1041-1050 of 1,512) with videos related to
Sort By:
Pageof 152
Leukemia & Lymphoma|May 19, 2011
Clinical dissection of multicentric Castleman diseaseDong-Yeop Shin, Yoon Kyung Jeon, Yong-Sang Hong, et al.Stroke|December 21, 2018
Ceria Nanoparticles Synthesized With Aminocaproic Acid for the Treatment of Subarachnoid HemorrhageHan-Gil Jeong, Bong Geun Cha, Dong-Wan Kang, et al.Biochemical and Biophysical Research Communications|December 3, 2014
Tetrahydropalmatine promotes myoblast differentiation through activation of p38MAPK and MyoDSang-Jin Lee, Miran Yoo, Ga-Yeon Go, et al.The American Journal of Pathology|March 13, 2017
Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal TypeSung Hoon Sim, Soyeon Kim, Tae Min Kim, et al.Cancer Research and Treatment|February 18, 2015
Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR MutationsSehhoon Park, Bhumsuk Keam, Se Hyun Kim, et al.Viruses|July 27, 2024
Establishment of the Foot-and-Mouth Disease Virus Type Asia1 Expressing the HiBiT Protein: A Useful Tool for a NanoBiT Split Luciferase AssayGiyoun Cho, Hyejin Kim, Dong-Wan Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2018
Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung CancerBenjamin J Solomon, Dong-Wan Kim, Yi-Long Wu, et al.Molecular Neurodegeneration|January 16, 2022
Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkersJun Wang, Dong-Yu Fan, Hui-Yun Li, et al.Cancer|December 12, 2003
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosageKeun-Wook Lee, Dae-Young Kim, Tak Yun, et al.Cancer Research and Treatment|July 14, 2017
Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung CancerMakoto Nishio, Dong-Wan Kim, Yi-Long Wu, et al.Pageof 152